Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Alexandra Martínez Roca"'
Autor:
Carlos Jimenez-Vicente, Francesca Guijarro, Monica Lopez-Guerra, Ares Guardia-Torrelles, Alexandra Martínez Roca, Alex Bataller, Daniel Esteban, Albert Cortés, Inés Zugasti, Daniel Munarriz, Dolors Colomer, Marina Diaz-Beya, Jordi Esteve
Publikováno v:
HemaSphere, Vol 7, p e706751a (2023)
Externí odkaz:
https://doaj.org/article/0213564e9f46404ca5440637e0a6c2b8
Autor:
Ares Guardia-Torrelles, Carlos Jimenez-Vicente, Alexandra Martínez Roca, Sandra Castaño-Díez, Helena Brillembourg, Francesca Guijarro, Àlex Bataller, Daniel Esteban, Albert Cortés, Inés Zugasti, Daniel Munarriz, Marina Diaz-Beya, Jordi Esteve, Beatriz Merchan
Publikováno v:
HemaSphere, Vol 7, p e32922f1 (2023)
Externí odkaz:
https://doaj.org/article/3c68b11e084c49b19ea647cea61321e1
Autor:
Valentín Ortiz-Maldonado, Nuria Martinez-Cibrian, Marta Español-Rego, Guillermo Muñoz-Sanchez, Sergio Navarro, Leticia Alserawan, Maria Castella, Daniel Benitez-Ribas, Laura Magnano, Eva Gine, Luis Gerardo Rodríguez Lobato, Alexandra Martínez Roca, Helena Brillembourg, Mercedes Montoro, Pilar Ayora, Carlos Fernandez de Larrea, Mariona Pascal, Jordi Esteve, Avaro Urbano Ispizua, Manel Juan, Julio Delgado
Publikováno v:
HemaSphere, Vol 7, p e97357cb (2023)
Externí odkaz:
https://doaj.org/article/353b639924cd4a21aab34baf0da7e62d
Autor:
Nuria Martinez-Cibrian, Valentín Ortiz-Maldonado, Marta Español-Rego, Daniel Benitez-Ribas, Joan Cid, Miquel Lozano, Sergio Navarro, Laura Magnano, Eva Gine, Juan Gonzalo Correa Saldarriaga, Pablo Mozas, Luis Gerardo Rodríguez Lobato, Helena Brillembourg, Mercedes Montoro, Pilar Ayora, Leticia Alserawan, Alexandra Martínez Roca, Armando Lopez-Guillermo, Avaro Urbano Ispizua, Manel Juan, Mariona Pascal, Julio Delgado
Publikováno v:
HemaSphere, Vol 7, p e4838399 (2023)
Externí odkaz:
https://doaj.org/article/4cc0fa417f064bf2a92f41693b017ea0
Autor:
Valentín Ortiz-Maldonado, Gerard Frigola, Marta Español-Rego, Olga Balagué, Nuria Martínez-Cibrián, Laura Magnano, Eva Giné, Mariona Pascal, Juan G. Correa, Alexandra Martínez-Roca, Joan Cid, Miquel Lozano, Neus Villamor, Daniel Benítez-Ribas, Jordi Esteve, Armando López-Guillermo, Elías Campo, Álvaro Urbano-Ispizua, Manel Juan, Julio Delgado
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
CART19 cells are emerging as an alternative therapy for patients with chronic lymphocytic leukemia (CLL). Here we report the outcome of nine consecutive patients with CLL treated with ARI-0001 CART19 cells, six of them with Richter’s transformation
Externí odkaz:
https://doaj.org/article/6181d522f8dc416998fbf994486c46d2
Autor:
Sandra Castaño-Díez, Mónica López-Guerra, Cristina Bosch-Castañeda, Alex Bataller, Paola Charry, Daniel Esteban, Francesca Guijarro, Carlos Jiménez-Vicente, Carlos Castillo-Girón, Albert Cortes, Alexandra Martínez-Roca, Ana Triguero, José Ramón Álamo, Silvia Beà, Dolors Costa, Dolors Colomer, María Rozman, Jordi Esteve, Marina Díaz-Beyá
Publikováno v:
Cancers, Vol 14, Iss 17, p 4107 (2022)
Despite emerging molecular information on chronic myelomonocytic leukemia (CMML), patient outcome remains unsatisfactory and little is known about the transformation to acute myeloid leukemia (AML). In a single-center cohort of 219 CMML patients, we
Externí odkaz:
https://doaj.org/article/e16e6f6c51814c45826a9f06458cef01
Autor:
Luis-Gerardo Rodríguez-Lobato, Alexandra Martínez-Roca, Sandra Castaño-Díez, Alicia Palomino-Mosquera, Gonzalo Gutiérrez-García, Alexandra Pedraza, María Suárez-Lledó, Montserrat Rovira, Carmen Martínez, Carlos Fernández de Larrea, María-Teresa Cibeira, Laura Rosiñol, Ester Lozano, Pedro Marín, Joan Cid, Miquel Lozano, Ana Belén Moreno-Castaño, Marta Palomo, Maribel Díaz-Ricart, Cristina Gallego, Adelina Hernando, Susana Segura, Enric Carreras, Álvaro Urbano-Ispizua, Joan Bladé, Francesc Fernández-Avilés
Publikováno v:
PLoS ONE, Vol 15, Iss 11, p e0241778 (2020)
BackgroundAutologous stem cell transplantation (ASCT) remains the standard of care for young multiple myeloma (MM) patients; indeed, at-home ASCT has been positioned as an appropriate therapeutic strategy. However, despite the use of prophylactic ant
Externí odkaz:
https://doaj.org/article/556d3445100b4b6eb3408d586cb3c692
Autor:
Valentín Ortiz‐Maldonado, Anna Alonso‐Saladrigues, Marta Español‐Rego, Nuria Martínez‐Cibrián, Anna Faura, Laura Magnano, Albert Català, Daniel Benítez‐Ribas, Eva Giné, Marina Díaz‐Beyá, Juan Gonzalo Correa, Montserrat Rovira, Mercedes Montoro‐Lorite, Alexandra Martínez‐Roca, Luis Gerardo Rodríguez‐Lobato, Raquel Cabezón, Joan Cid, Miquel Lozano, Enric Garcia‐Rey, Nuria Conde, Georgina Pedrals, María Rozman, Montserrat Torrebadell, Xavier Setoain, Sonia Rodríguez, Jordi Esteve, Mariona Pascal, Álvaro Urbano‐Ispizua, Manel Juan, Julio Delgado, Susana Rives
Publikováno v:
AMERICAN JOURNAL OF HEMATOLOGY
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Universidad de las Islas Baleares
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Universidad de las Islas Baleares
We evaluated outcomes of 18 patients with isolated extramedullary disease (iEMD) relapsed/refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL) treated with the CD19-directed CAR T cells ARI-0001 in two centers (adult and pediatric), including
Autor:
Luis Gerardo Rodríguez-Lobato, Anna de Daniel i Bisbe, Natalia Tovar, Raquel Jiménez-Segura, M. Teresa Cibeira, David F. Moreno, Aina Oliver-Caldes, Alexandra Martínez-Roca, Ester Lozano, Joan Bladé Creixenti, Laura Rosinol Dachs, Carlos Fernandez de Larrea
Publikováno v:
Blood. 140:4341-4342
Autor:
Elena Guillen, Adriana García-Herrera, Sara Fernández, Esteban Poch, Josep M. Campistol, Alexandra Martínez-Roca, Joan Bladé, Miquel Blasco, Carlos Fernández de Larrea, María Teresa Cibeira, Luis F. Quintana, Marta Palomo, Natalia Tovar, Pedro Castro, Maribel Diaz-Ricart, Enric Carreras, Laura Rosiñol, Raquel Jiménez, Luis G. Rodríguez‐Lobato
Publikováno v:
British Journal of Haematology. 193:181-187
Carfilzomib has been associated with the development of thrombotic microangiopathy (TMA) in relapsed/refractory multiple myeloma patients, a severe disease with no currently available aetiological treatment. We evaluated the potential role of termina